Practice
Featured experience
Emerson $7.2 billion acquisition of remaining outstanding shares of AspenTech
We are advising Emerson on its acquisition
Intra-Cellular Therapies $14.6 billion acquisition by Johnson & Johnson
We are advising Intra-Cellular Therapies on the transaction
GSK up to $1.15 billion acquisition of IDRx
We are advising GSK on the transaction
Royalty Pharma $1.1 billion acquisition of its external manager and $3 billion share repurchase
We are advising Royalty Pharma on the transaction
PGT Innovations $3 billion acquisition by Masonite International
We are advising PGT Innovations on the transaction
Rialto JV for Signature Bank loan portfolio with FDIC, Blackstone and CPPIB
We advised Rialto Capital on the joint venture
Atairos investment in the parent company of the Aston Villa Football Club
We are advising Atairos on the minority investment
Hollysys Automation $1.66 billion acquisition by Ascendent Capital Partners
We are advising Hollysys on the acquisition
Penguin Random House acquisition of Hay House
We are advising Penguin Random House on the acquisition
GoTo $1.5 billion strategic e-commerce partnership with TikTok
We are advising GoTo on its strategic partnership with TikTok
Veoneer sale of Restraint Control Systems business to AIP
We are advising Veoneer and SSW Partners on the sale
Cubic Telecom €473 million strategic investment by SoftBank
We are advising Cubic Telecom on the strategic investment
Tencent $100 million strategic investment in Global Blue Group Holding
We advised Tencent on the transaction
Cadre sale to Yieldstreet
We are advising Cadre on the transaction